FOXP2 and esophageal cancer: The immunohistochemistry results showed that the expression of FOXP2 in cytoplasm increased with the pathological grade, which was similar to the decreasing cytoplasmic expression of transcription factor ZEB1 in tumor tissues of patients with low grade esophageal cancer [45].